Connect with us

News

Nigeria, South Africa, 4 others to begin production of COVID-19 vaccines

Published

on

COVID-19: Global cases reach 1.5m, as WHO challenges US, China

The World Health Organisation (WHO) said on Friday Nigeria and five other countries in Africa had been chosen to begin the production of COVID-19 vaccines on the continent.

The other five countries are Egypt, Kenya, Senegal, South Africa, and Tunisia.

The WHO Director-General, Tedros Ghebreyesus, disclosed this at a media briefing in Geneva.

He said the six countries were selected as the first recipients of technology from the WHO global mRNA vaccine hub in a bid to fast-track the production of vaccines to tackle COVID-19 and other diseases in Africa.

READ ALSO: Vaccines produced now not best for Africa —Expert warns

Ghebreyesus said: “Today I’m delighted to announce the first six African countries that will receive technology from the hub to produce their own mRNA vaccines: Egypt, Kenya, Nigeria, Senegal, South Africa, and Tunisia.

“I was honoured to visit the Hub last week. And it’s already producing results, with Afrigen’s announcement that it has produced its own mRNA vaccine, based on publicly-available information about the composition of an existing vaccine.

 

“We expect clinical trials to start in the 4th quarter of this year, with approval expected in 2024. We expect the benefits of this initiative will extend far beyond #COVID19 by creating a platform for vaccines against other diseases including malaria and tuberculosis.”

 

Join the conversation

Opinions

Support Ripples Nigeria, hold up solutions journalism

Balanced, fearless journalism driven by data comes at huge financial costs.

As a media platform, we hold leadership accountable and will not trade the right to press freedom and free speech for a piece of cake.

If you like what we do, and are ready to uphold solutions journalism, kindly donate to the Ripples Nigeria cause.

Your support would help to ensure that citizens and institutions continue to have free access to credible and reliable information for societal development.

Donate Now

Investigations